Open AccessAdvances in Pharmacotherapy of Hepatocellular Carcinoma: A State-of-the-Art Review
Author(s) -
Florian P. Reiter,
Najib Ben Khaled,
Liangtao Ye,
Changhua Zhang,
Max Seidensticker,
Mark op den Winkel,
Gerald Denk,
Andreas Geier,
Enrico N. De Toni
Publication year - 2021
Publication title -
digestive diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.879
H-Index - 66
eISSN - 1421-9875
pISSN - 0257-2753
DOI - 10.1159/000520095
Subject(s) - medicine , sorafenib , hepatocellular carcinoma , systemic therapy , oncology , combination therapy , disease , targeted therapy , pharmacotherapy , cancer , breast cancer
Due to the number of emerging new treatment options, the systemic treatment of hepatocellular carcinoma (HCC) is rapidly changing. We provide here an overview of the current landscape of systemic treatment of HCC and discuss its potential future development.